卡托普利预防放射性膀胱损伤:一项小鼠研究
该临床前研究用C57BL/6雄性小鼠探讨血管紧张素转换酶抑制剂(ACEi)卡托普利对盆腔放疗所致膀胱损伤的保护作用。小鼠在膀胱局部X线照射前5天开始口服卡托普利0.3 g/L并持续至照射后20周,结果显示卡托普利可预防照射引起的排尿模式改变及尿液细胞外囊泡、CCL2、MIP-2和循环炎症细胞增加。作者结论为肾素-血管紧张素系统(RAS)全身调节可预防并减轻放疗所致晚期膀胱损伤,但需更大规模验证性研究。
要点
- 单次30 Gy或8 Gy×3分次膀胱照射后>14周出现尿频和单次排尿量减少,4周时未见。
- 尿路上皮厚度与单次排尿量正相关(P=.0428)、与排尿次数负相关(P=.028)。
- 卡托普利预防了照射引起的排尿模式改变及尿液囊泡和炎症指标升高。
核心结论
- 本研究表明全身调节RAS可预防并减轻放疗所致晚期膀胱损伤,但需更大规模验证性研究。
研究设计与样本
- 临床前研究,C57BL/6雄性小鼠接受口服ACEi卡托普利0.3 g/L,自膀胱局部X线照射前5天开始并维持至照射后20周。
- 照射采用XStrahl SARRP Muriplan CT图像引导、平行对穿侧野,单次30 Gy或5天内3次8 Gy。
- 膀胱毒性通过尿液分析、功能性排尿、膀胱释放外泌体、组织病理学及循环炎症免疫细胞评估。
主要发现
- 与未照射动物相比,单次和分次照射在>14周时增加排尿频率并减少单次排尿量,4周时未见。
- 尿路上皮厚度与单次排尿量正相关(P=.0428)、与排尿次数负相关(P=.028)。
- 卡托普利治疗预防了照射引起的慢性排尿模式改变。
- 膀胱局部照射显著增加尿液细胞外囊泡平均颗粒计数及单核细胞和中性粒细胞趋化因子CCL2和MIP-2,并增加循环炎症性中性粒细胞和单核细胞比例,卡托普利同样预防了这些变化。
- 膀胱组织探索性转录组分析提示炎症和红细胞生成通路。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文结论指出需更大规模验证性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pelvic radiation therapy (RT) can cause debilitating bladder toxicities but few clinical interventions exist to prevent injury or alleviate symptoms. From a large genome-wide association study in patients with prostate cancer it was previously reported that SNPs tagging AGT, part of the renin-angiotensin system (RAS), correlated with patient-reported late hematuria, identifying a potential targetable pathway to prevent RT-induced bladder injury. To investigate this association, we performed a preclinical study to determine whether RAS modulation protected the bladder against RT injury. METHODS AND MATERIALS: C57BL/6 male mice were treated with an oral angiotensin converting enzyme inhibitor (ACEi: 0.3g/L captopril) 5 days before focal bladder X-irradiation with either single dose (SD) 30 Gy or 3 fractions of 8 Gy (8 Gy × 3 in 5 days). RT was delivered using XStrahl SARRP Muriplan CT-image guidance with parallel-opposed lateral beams. ACEi was maintained for 20 weeks post RT. Bladder toxicity was assessed using assays to identify local injury that included urinalysis, functional micturition, bladder-released exosomes, and histopathology, as well as an assessment of systemic changes in inflammatory-mediated circulating immune cells. RESULTS: SD and fractionated RT increased urinary frequency and reduced the volume of individual voids at >14 weeks, but not at 4 weeks, compared with nonirradiated animals. Urothelial layer width was positively correlated with mean volume of individual voids (P = .0428) and negatively correlated with number of voids (P = .028), relating urothelial thinning to changes in RT-mediated bladder dysfunction. These chronic RT-induced changes in micturition patterns were prevented by captopril treatment. Focal bladder irradiation significantly increased the mean particle count of urine extracellular vesicles and the monocyte and neutrophil chemokines CCL2 and MIP-2, and the proportions of circulating inflammatory-mediated neutrophils and monocytes, which was also prevented by captopril. Exploratory transcriptomic analysis of bladder tissue implicated inflammatory and erythropoietic pathways. CONCLUSIONS: This study demonstrated that systemic modulation of the RAS protected against and alleviated RT-induced late bladder injury but larger confirmatory studies are needed.
引用
- Groves AM, Paris N, Hernady E, et al. Prevention of Radiation-Induced Bladder Injury: A Murine Study Using Captopril. Int J Radiat Oncol Biol Phys. 2022. PMID: 36400304. doi:10.1016/j.ijrobp.2022.10.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。